VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2022 | The advances and limitations of genetic testing for actionable mutations

Luis Montuenga, MD, Clinica Universidad de Navarra, Pamplona, Spain, talks on the advances in genetic testing for actionable mutations, including in technologies that can provide multiple mutational analysis. The limitations of biomarker testing are additionally discussed, including the lack of accessibility to biomarker analysis for some patients. This interview took place during the virtual European Lung Cancer Congress 2022.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter